Sangamo Therapeutics
Clinical trials sponsored by Sangamo Therapeutics, explained in plain language.
-
15-Year watch begins for experimental transplant therapy
Disease control OngoingThis study follows 11 kidney transplant patients who received an experimental cell therapy called TX200-TR101 in an earlier trial. Researchers will monitor them for up to 15 years to check for long-term side effects and how well their transplanted kidney is doing. The goal is to …
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy patients monitored for years to ensure lasting safety
Disease control OngoingThis study follows 8 people who received a one-time gene therapy (BIVV003 for sickle cell disease or ST-400 for beta-thalassemia) to see if it remains safe and effective over many years. Researchers will track serious side effects, survival, and blood markers like hemoglobin leve…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC